Hepatitis B & C in Asia - Tapping the opportunity of high prevalence rates in China, Taiwan, South Korea and Turkey

China, Taiwan, South Korea and Turkey represent highly endemic areas for viral Hepatitis. For this report, 180 high-prescribing physicians where surveyed in these countries, providing a breakdown of numbers of treated patients and the most frequently prescribed regimens.

While HBV vaccination and blood screening practices have reduced the prevalence of hepatitis B and C, the disease burden in East Asia still remains significantly higher than in the 7MM. Prevalence of HBV across China, South Korea and Turkey ranges from 4-8% but exceeds 10% in Taiwan. The prevalence of HCV across these countries ranges from 1-4%.

Zeffix and Baraclude, either alone or in combination with other antiviral agents, are the most frequently prescribed drugs to treat hepatitis B.

Treatment regimens for HCV across the four countries are more uniform due to the availability of only a few therapeutic options. In all four markets, Pegasys and ribavirin is the most frequently prescribed combination for first line therapy. Options for second line are limited if patients fail on current standard of care.

Read more...

Comments

Add New Search RSS

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Market & Patient Access (17/04/2013)
• Asia-Pacific Region (06/09/2010)
• Key Asia Pacific Markets (30/06/2009)

• Osteoporosis (10/06/2010)
• Nerve Growth Factor (24/05/2010)
• Therapeutic Cancer Vaccines (07/05/2010)

• Medical Devices (26/04/2010)
• Nonalcoholic Steatohepatitis (26/04/2010)
• HIV/AIDS (26/04/2010)
• Global Diagnostic ECG Market (15/04/2010)
• IVD Market in BRIC Countries (15/04/2010)
• Drug Delivery (06/04/2010)
• Pharmaceutical Key Trends 2010 (06/04/2010)
• Infant Care (06/04/2010)
• Osteoarthritis (16/02/2010)

---